Fresenius Medical Care provides an overview of the analysts’ recommendations and the consensus estimates.
Shareholder structure
In the analysis of our shareholder structure as of December 31, 2025, approximately 93% of the free float was attributed to its respective owners. Accordingly, Fresenius SE & Co. KGaA remained the largest shareholder after reducing its stake from approximately 94.4 M to 81.6 M shares, translating into around 27.8% of the issued shares. Reflecting this reduction and the implemented share buyback program, the percentage of shares in free float amounts to around 67% of the share capital. Additionally, 12 institutional investors were identified as holding at least 1% of the share capital.
In total, 582 institutional investors held shares in Fresenius Medical Care. The 20 largest among them accounted for approximately 58% of the identified free float (2024: 63%).
In terms of geographical distribution, as of December 31, 2025, 67.1% of the institutional free float was held by investors based in the U.S. and Canada, 11.6% by investors in the United Kingdom, 7.1% by investors in Germany, and 4.7% by investors in France.
Number of identified shares as per shareholder structure analysis
| Number of shares in M | Number of shares in % of issued share capital | |
|---|---|---|
| Identified shares | 278.9 | 95 |
| Unidentified shares | 14.5 | 5 |
| Number of issued shares | 293.4 | 100 |
| Number of issued shares | 293.4 | 100 |
| Treasury shares | 14.5 | 5 |
| Number of shares outstanding | 279.3 | 95 |
| Number of shares outstanding | 279.3 | 95 |
| Fresenius SE & Co. KGaA | 81.6 | 28 |
| Shares in free float | 197.7 | 67 |
Geographical distribution of identified shares in free float
Related Content
-
-
Read more about our share data, stock exchange listings and index membership.
No Results Found